←Back to list

Galvanize Therapeutics

Pulsed electric field (PEF) ablation (Aliya system; RheOx for chronic bronchitis)
Galvanize Therapeutics (San Carlos, United States) — pulsed electric field (PEF) ablation (Aliya system; RheOx for chronic bronchitis). On November 16, 2026 it announced a $130M Series D, led by HealthQuest Capital. Oversubscribed. Prior: $100M Series C (Sep 2025). 4,000+ Aliya procedures. Funds go to commercial expansion and clinical evidence.
Healthcare 📍 San Carlos
Current Valuation
Private
PRIVATE

IPO Outlookprivate

Is Galvanize Therapeutics going public?
No. Galvanize Therapeutics is private and has not filed to go public. There is no S-1 on file.
What is Galvanize Therapeutics' valuation in 2026?
No confirmed valuation is on record for Galvanize Therapeutics. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Galvanize Therapeutics filed an S-1?
No public S-1 is on file for Galvanize Therapeutics.
Who are Galvanize Therapeutics' investors?
Galvanize Therapeutics' investors include HealthQuest Capital, Olympus Innovation Ventures, Braidwell LP, Sofinnova Partners, Norwest, Elevage Medical Technologies.
Is Galvanize Therapeutics publicly traded — can you buy Galvanize Therapeutics stock?
No. Galvanize Therapeutics is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Galvanize Therapeutics on its Pre-IPO Access Desk.
How to actually get exposure to Galvanize Therapeutics →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

HQ
San Carlos
Last Round
Series D — $130M (Nov 2026) · Lead: HealthQuest Capital
IPO Status
private

Fundraising Status

Series D · $130M · this month
private1 disclosed rounds

Funding History

RoundAmountDateLead InvestorPost-Money
Series D$130MNov 2026HealthQuest Capital—

Recent Activity

💰
Nov 2026 · MedTech Dive · funding

Talent Signal

Hiring data for Galvanize Therapeutics has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.

Investors

HealthQuest Capital · Olympus Innovation Ventures · Braidwell LP · Sofinnova Partners · Norwest · Elevage Medical Technologies
HealthcarePulsed electric field ablation
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.